This list represents publications directly from the SWAN Project team and its partners. Publications from external authors who have used the project's resources are not listed.
· Zhao Y, et al. Homogeneous and heterogeneous boosting in prostate radiotherapy: Treatment planning and target dosimetry comparison. Radiotherapy and Oncology. 2025;208. https://doi.org/10.1016/j.radonc.2025.110916
· Chlap, P., Min, H., Dowling, J., Field, M., Cloak, K., Leong, T., Lee, M., Chu, J., Tan, J., Tran, P., Kron, T., Sidhom, M., Wiltshire, K., Keats, S., Kneebone, A., Haworth, A., Ebert, M. A., Vinod, S. K., & Holloway, L. (2024). Uncertainty estimation using a 3D probabilistic U-Net for segmentation with small radiotherapy clinical trial datasets. Computerized Medical Imaging and Graphics, 116, 102403. https://doi.org/10.1016/j.compmedimag.2024.102403
· Zhao, Y., Haworth, A., Reynolds, H. M., Williams, S. G., Finnegan, R., Rowshanfarzad, P., & Ebert, M. A. (2024). Towards optimal heterogeneous prostate radiotherapy dose prescriptions based on patient-specific or population-based biological features. Med Phys. 10.1002/mp.16936. https://doi.org/10.1002/mp.16936
· Ryan, J., Hardcastle, N., Francis, R., Ferjančič, P., Ng, S. P., Koh, E.-S., Geso, M., Kelly, J., & Ebert, M. A. (2024). The impact of fluorine-18-fluoroethyltyrosine positron emission tomography scan timing on radiotherapy planning in newly diagnosed patients with glioblastoma. Physics and Imaging in Radiation Oncology, 29, 100536. https://doi.org/10.1016/j.phro.2024.100536
· Barry, N., Francis, R. J., Ebert, M. A., Koh, E.-S., Rowshanfarzad, P., Hassan, G. M., Kendrick, J., Gan, H. K., Lee, S. T., Lau, E., Moffat, B. A., Fitt, G., Moore, A., Thomas, P., Pattison, D. A., Akhurst, T., Alipour, R., Thomas, E. L., Hsiao, E., Schembri, G. P., Lin, P., Ly, T., Yap, J., Kirkwood, I., Vallat, W., Khan, S., Krishna, D., Ngai, S., Yu, C., Beuzeville, S., Yeow, T. C., Bailey, D., Cook, O., Whitehead, A., Dykyj, R., Rossi, A., Grose, A., & Scott, A. M. (2023). Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06. European Journal of Nuclear Medicine and Molecular Imaging, 50(13), 3970-3981. https://doi.org/10.1007/s00259-023-06371-5
· Zhao, Y., Haworth, A., Rowshanfarzad, P., & Ebert, M. A. (2023). Focal Boost in Prostate Cancer Radiotherapy: A Review of Planning Studies and Clinical Trials. Cancers, 15(19), 4888. https://doi.org/10.3390/cancers15194888
· Kendrick, J., Francis, R. J., Hassan, G. M., Rowshanfarzad, P., Ong, J. S. L., Jeraj, R., Barry, N., Hagan, T., & Ebert, M. A. (2023). Prospective inter- and intra-tracer repeatability analysis of radiomics features in [(68)Ga]Ga-PSMA-11 and [(18)F]F-PSMA-1007 PET scans in metastatic prostate cancer. The British journal of radiology, 96(1152), 20221178. https://doi.org/10.1259/bjr.20221178
· Min, H., Dowling, J., Jameson, M. G., Cloak, K., Faustino, J., Sidhom, M., Martin, J., Cardoso, M., Ebert, M. A., Haworth, A., Chlap, P., de Leon, J., Berry, M., Pryor, D., Greer, P., Vinod, S. K., & Holloway, L. (2023). Clinical target volume delineation quality assurance for MRI-guided prostate radiotherapy using deep learning with uncertainty estimation. Radioth Oncol, 186, 109794. https://doi.org/10.1016/j.radonc.2023.109794
· Kendrick, J., Francis, R. J., Hassan, G. M., Rowshanfarzad, P., Ong, J. S. L., McCarthy, M., Alexander, S., & Ebert, M. A. (2023). Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET images. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06382-2
· Cicchetti, A., Fiorino, C., Ebert, M. A., Iacovacci, J., Kennedy, A., Joseph, D. J., Denham, J. W., Vavassori, V., Fellin, G., Cozzarini, C., Degli Esposti, C., Gabriele, P., Munoz, F., Avuzzi, B., Valdagni, R., & Rancati, T. (2023). Validation of prediction models for radiation-induced late rectal bleeding: evidence from a large pooled population of prostate cancer patients. Radiotherapy and Oncology, 109628. https://doi.org/10.1016/j.radonc.2023.109628
· Zhao, Y., Haworth, A., Reynolds, H. M., Her, E. J., Sun, Y., Finnegan, R., Rowshanfarzad, P., & Ebert, M. A. (2023). Patient-specific voxel-level dose prescription for prostate cancer radiotherapy consi ering tumor cell density and grade distribution. Medical Physics, 50(6): 3746-3761. https://doi.org/10.1002/mp.16264
· Kendrick, J., Francis, R. J., Hassan, G. M., Rowshanfarzad, P., Ong, J. S. L., & Ebert, M. A. (2022). Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [(68)Ga]Ga-PSMA-11 PET/CT images. Eur J Nucl Med Mol Imaging. 50(1): 67-79. https://doi.org/10.1007/s00259-022-05927-1
· Finnegan, R. N., Reynolds, H. M., Ebert, M. A., Sun, Y., Holloway, L., Sykes, J. R., Dowling, J., Mitchell, C., Williams, S. G., Murphy, D. G., & Haworth, A. (2022). A statistical, voxelised model of prostate cancer for biologically optimised radiotherapy. Physics and Imaging in Radiation Oncology, 21, 136-145. https://doi.org/10.1016/j.phro.2022.02.011
· de Chavez R, Grogan G, Hug B, Howe K, Grigg A, Waterhouse D, et al. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2022. https://doi.org/10.1016/j.meddos.2021.08.003
· Ebert, M. A., Gulliford, S., Acosta, O., de Crevoisier, R., McNutt, T., Heemsbergen, W. D., Witte, M., Palma, G., Rancati, T., & Fiorino, C. (2021). Spatial descriptions of radiotherapy dose: normal tissue complication models and statistical associations. Physics in Medicine & Biology, 66(12), 12TR01. https://doi.org/10.1088/1361-6560/ac0681
· Marcello M, Denham J W, Kennedy A, Haworth A, Steigler A, Greer P B, Holloway L C, Dowling J A, Jameson M G, Roach D, Joseph D J, Gulliford S L, Dearnaley D P, Sydes M R, Hall E and Ebert M A 2020 Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trials Radiotherapy and Oncology 150 281-92, https://doi.org/10.1016/j.radonc.2020.07.048
· Marcello M, Denham J W, Kennedy A, Haworth A, Steigler A, Greer P B, Holloway L C, Dowling J A, Jameson M G, Roach D, Joseph D J, Gulliford S L, Dearnaley D P, Sydes M R, Hall E and Ebert M A 2020 Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials Int J Radiat Oncol Biol Phys 108 1304-18, https://doi.org/10.1016/j.ijrobp.2020.07.030
· Mylona E, Ebert M, Kennedy A, Joseph D, Denham J, Steigler A, Supiot S, Acosta O and de Crevoisier R 2020 Rectal and Urethro-Vesical Subregions for Toxicity Prediction After Prostate Cancer Radiation Therapy: Validation of Voxel-Based Models in an Independent Population International Journal of Radiation Oncology*Biology*Physics 108 1189-95, https://doi.org/10.1016/j.ijrobp.2020.07.019
· Her EJ, Haworth A, Reynolds HM, Sun Y, Kennedy A, Panettieri V, Bangert M, Williams S, Ebert MA (2020) Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI, Radiat Oncol, 15: 172, https://doi.org/10.1186/s13014-020-01568-6
· Marcello M, Denham JW, Kennedy A, Haworth A, Steigler A, Greer PB, Holloway LC, Dowling JA, Jameson MG, Roach D, Joseph DJ, Gulliford SL, Dearnaley DP, Sydes MR, Hall E, Ebert MA (2020) Increased dose to organs in urinary tract associates with measures of genitourinary toxicity in pooled voxel-based analysis of 3 randomized Phase III trials, Front Oncol, 10: 1174, https://doi.org/10.3389/fonc.2020.01174
· Panettieri V, Rancati T, Onjukka E, Ebert MA, Joseph DJ, Denham JW, Steigler A, Millar JL (2020) External validation of a predictive model of urethral strictures for prostate patients treated with HDR brachytherapy boost, Frontiers in Oncology, 10: 910, https://doi.org/10.3389/fonc.2020.00910
· Her EJ, Haworth A, Rowshan Farzad P, Ebert MA (2020) Progress towards patient-specific, spatially-continuous radiobiological dose prescription and planning in prostate cancer IMRT: An overview, Cancers 12(4) E854, https://doi.org/10.3390/cancers12040854
· Joseph DJ, Denham JW, Steigler A, Lamb DS, Spry NA, Stanley J, Shannon T, Duchesne G, Atkinson C, Matthews JHL, Turner S, Kenny L, Christie D, Tai K-H, Gogna NK, Kearvell R, Murray J, Ebert MA, Haworth A, Delahunt B, Oldmeadow C, Attia J (2020) Radiation dose escalation or longer androgen suppression to prevent distant progression in men with locally advanced prostate cancer? 10 year data from the TROG 03.04 RADAR trial, Int J Radiat Oncol Biol Phys, 106(4): 693-702, doi: 10.1016/j.ijrobp.2019.11.415 Kennedy A, Dowling JA, Greer PB, Holloway LC, Jameson MG, Roach D, Ghose S, Rivest‐Hénault D, Marcello M, Ebert MA (2019) Similarity clustering-based atlas selection for pelvic CT image segmentation, Med Phys, 46(5):2243-2250, https://doi.org/10.1002/mp.13494
· Roach D, Holloway LC, Jameson MG, Dowling JA, Kennedy A, Greer PB, Krawiec M, Rai R, Denham JW, De Leon J, Lim K, Berry ME, White RT, Bydder SA, Tan HT, Croker JD, McGrath A, Matthews J, Smeenk RJ, Ebert MA (2019) Multi-observer contouring of male pelvic anatomy: Highly variable agreement across conventional and emerging structures of interest, J Med Imag Radiat Oncol, 63(2):264-271, https://doi.org/10.1111/1754-9485.12844
· Kennedy A, Dowling J, Greer P, Ebert MA (2018) Estimation of Hounsfield Unit conversion parameters for pelvic CT images, Aust Phys Eng Sci Med, 41(3): 739-745, doi: 10.1007/s13246-018-0651-x
· Roach D, Jameson MG, Dowling JA, Ebert MA, Greer PB, Kennedy AM, Watt S, Holloway LC (2018) Correlations between contouring similarity metrics and simulated treatment outcome for prostate radiotherapy. Phys Med Biol, 63(3) 035001, https://doi.org/10.1088/1361-6560/aaa50c
· Marcello M, Ebert MA, Haworth A, Steigler A, Kennedy A, Joseph DJ, Denham JW (2018) Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: results from the TROG 03.04 RADAR trial, Radioth Oncol, 126(2): 249-256. https://doi.org/10.1016/j.radonc.2017.10.021
· Marcello M, Ebert MA, Haworth A, Steigler A, Kennedy A, Bulsara M, Kearvell R, Joseph DJ, Denham JW (2018) Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: results from the TROG 03.04 RADAR trial, J Med Imag Radiat Oncol, 62(2): 248-255, https://doi.org/10.1111/1754-9485.12695
· Gulliford SL, Ghose S, Ebert MA, Kennedy A, Dowling J, Mitra J, Joseph DJ, Denham JW (2017) Radiotherapy dose-distribution to the perirectal fat space (PRS) is related to gastrointestinal control-related complications, Clin Transl Radiat Oncol, 7:62-70, https://doi.org/10.1016/j.ctro.2017.10.002
· Moulton CR, House MJ, Lye V, Tang CI, Krawiec M, Joseph DJ, Denham JW, Ebert MA (2017) Spatial features of dose-surface maps from deformably-registered plans correlate with late gastrointestinal complications, Phys Med Biol, 62(10):4118-4139, https://doi.org/10.1088/1361-6560/aa663d
· Moulton CR, House MJ, Lye V, Tang CI, Krawiec M, Joseph DJ, Denham JW, Ebert MA (2017) Accumulation of rectum dose-volume metrics for prostate external beam radiotherapy combined with brachytherapy: evaluating deformably-registered dose distribution addition using parameter-based addition, J Med Imag Radiat Oncol, 61(4):534-542, https://doi.org/10.1111/1754-9485.12593
· Ghose S, Denham JW, Ebert MA, Kennedy A, Mitra J, Dowling J (2016) Multi-atlas and unsupervised learning approach to perirectal space segmentation in CT images, Aust Phys Eng Sci Med, 39(4): 933-941, https://doi.org/10.1007/s13246-016-0496-0
· Yahya N, Ebert MA, House MJ, Kennedy A, Matthews J, Joseph DJ, Denham JW (2017) Modelling urinary dysfunction after external beam radiotherapy of the prostate using bladder dose-surface maps: evidence of spatially-variable response of the bladder surface, Int J Radiat Oncol Biol Phys, 97(2): 420-426 https://doi.org/10.1016/j.ijrobp.2016.10.024
· Cicchetti A, Rancati T, Ebert MA, Fiorino C, Palorini F, Kennedy A, Joseph DJ, Denham JW, Vavassori V, Fellin G, Valdagni R (2016) Modelling late stool frequency and rectal pain after radical radiotherapy in prostate cancer patients: results from a large pooled population, Physica Medica, 32(12): 1690-1697, https://doi.org/10.1016/j.ejmp.2016.09.018
· Yahya A, Ebert MA, Bulsara M, Kennedy A, Joseph DJ, Denham JW (2016) Independent external validation of predictive urinary symptoms models following external beam radiotherapy of the prostate: issues in model development and reporting, Radioth Oncol, 120(2): 339-345, https://doi.org/10.1016/j.radonc.2016.05.010
· Yahya A, Ebert MA, Bulsara M, House MJ, Kennedy A, Joseph DJ, Denham JW (2016) Statistical-learning strategies generate only modestly-performing predictive models for urinary symptoms following external beam radiotherapy of the prostate: a comparison of conventional and machine-learning methods, Med Phys, https://doi.org/43:2040-2052, http://dx.doi.org/10.1118/1.4944738
· Yahya A, Ebert MA, Bulsara M, House MJ, Kennedy A, Joseph DJ, Denham JW (2015) Urinary symptoms following external beam radiotherapy of the prostate cancer: dose-symptom correlates with multiple-event and event-count models, Radioth Oncol, 117(2): 277-282, http://dx.doi.org/10.1016/j.radonc.2015.10.003
· Denham JW, Steigler A, Joseph D, Lamb DS, Spry NA, Duchesne G, Atkinson C, Matthews J, Turner S, Kenny L, Tai, K-H, Gogna NK, Gill S, Tan H, Kearvell R, Murray J, Ebert M, Haworth A, Kennedy A, Delahunt B, Oldmeadow C, Holliday EG, Attia J (2015) Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial, Radioth Oncol, 115(3):301-7 https://doi.org/10.1016/j.radonc.2015.05.016
· Moulton C, Ebert MA, House M, Lye V, Tang C, Krawiec M, St Pierre T, Joseph DJ, Denham JW (2015) Registering prostate external beam radiotherapy with a boost from high-dose-rate brachytherapy: a comparative evaluation of deformable registration algorithms, Radiat Oncol, 10:254
· Yahya A, Ebert MA, Bulsara M, Steigler A, Haworth A, Kennedy A, Joseph DJ, Denham JW (2015) Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: An analysis of data from the RADAR prostate radiotherapy trial, Radioth Oncol, 116:112-118, https://doi/org/10.1016/j.radonc.2015.06.011
· Ebert MA, Foo K, Haworth A, Gulliford SL, Kennedy A, Joseph DJ, Denham JW (2015) Gastro-intestinal dose-histogram effects in the context of dose-volume constrained prostate radiotherapy: an analysis of data from the RADAR prostate radiotherapy trial, Int J Radiat Oncol Biol Phys, 91(3):595-603, http://dx.doi.org/10.1016/j.ijrobp.2014.11.015
· Ebert MA, Bulsara M, Haworth A, Kearvell R, Richardson S, Kennedy A, Spry NA, Bydder S, Joseph DJ, Denham JW (2015) Technical quality assurance during the TROG 03.04 ‘RADAR’ prostate radiotherapy trial: are the results reflected in observed toxicity rates? J Med Imag Radiat Oncol, 59(1):99-108, https://doi.org/10.1111/1754-9485.12212
· Yahya A, Ebert MA, Bulsara M, Haworth A, Kearvell R, Foo K, Kennedy A, Richardson S, Krawiec M, Joseph DJ, Denham JW (2014) Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial, Radiat Oncol, 9(1):282 https://goi.org/10.1186/s13014-014-0282-7
· Ebert MA, Gulliford S, Buettner F, Foo K, Haworth A, Kennedy A, Joseph DJ, Denham DW (2014) Two non-parametric methods for derivation of constraints from radiotherapy dose-histogram data, Phys Med Biol 59:N101-111, https://doi.org/10.1088/0031-9155/59/13/N101
· Chang D, Joseph DJ, Ebert MA, Galvão DA, Taaffe DR, Denham JW, Newton RU, Spry NA (2014) The effect of androgen deprivation therapy on muscle attenuation in men with prostate cancer, J Med Imag Radiat Oncol, 58(2):223-228, https://doi.org/10.1111/1754-9485.12124
· Kennedy A, Lane J, Ebert MA (2014) An investigation of the impact of variations of DVH calculation algorithms on DVH dependant radiation therapy plan evaluation metrics, J Phys Conf Ser, 489: 012093, https://doi.org/10.1088/1742-6596/489/1/012093
· Carolan M, Oborn B, Foo K, Haworth A, Gulliford S, Ebert MA (2014) An MLE method for finding LKB NTCP model parameters using Monte Carlo uncertainty estimates, J Phys Conf Ser, 489: 012087,0020 https://doi.org/10.1088/1742-6596/489/1/012087
· Ebert MA, Foo K, Haworth A, Gulliford S, Kearvell R, Kennedy A, Richardson S, Krawiec M, Stewart N, Joseph DJ, Denham JW (2014) Derivation and representation of dose-volume response from large clinical trial data sets: an example from the RADAR prostate radiotherapy trial, J Phys Conf Ser, 489: 012090, https://doi.org/10.1088/1742-6596/489/1/012090
· Geraghty JP, Grogan G, Ebert MA (2013) Automatic segmentation of male pelvic anatomy on computed tomography images: a comparison with multiple observers in the context of a multicentre clinical trial, Rad Oncol, 8:106, https://doi.org/10.1186/1748-717X-8-106
· Ghose S, Denham JW, Ebert MA, Kennedy A, Dowling J (2013) Multi-atlas and Gaussian mixture modeling based perirectal fat segmentation from CT images MICCAI 2013, in Yoshida et al (eds) Abdominal imaging 2013, LNCS 8198, pp194-202
· Kearvell R, Haworth A, Ebert MA, Murray J, Hooton B, Richardson S, Joseph DJ, Lamb D, Duchesne G, Denham JW (2013) Quality improvements in prostate radiotherapy: Outcomes and impact of comprehensive quality assurance during the TROG 03.04 ‘RADAR’ trial, J Med Imag Radiat Oncol, 57(2):247-257, https://doi.org/10.1111/1754-9485.12025
· Denham JW, Wilcox C, Lamb DS, Spry NA, Duchesne G, Atkinson C, Matthews J, Turner S, Kenny L, Tai K-H, Gogna NK, Ebert M, Delahunt B, McElduff P, Joseph D (2012) Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer, Radioth Oncol, 105: 184-192
· Ebert MA, McDermott LN, Haworth A, van der Wath E, Hooton B (2012) Tools to analyse and display variations in anatomical delineation, Australas Phys Eng Sci Med, 35:159-164
· Ebert MA, Lamb DS, Joseph DJ, Steigler A, Denham DW (2011) A methodology for the analysis of PSA response signatures, Radioth Oncol, 98: 198-202
· Ebert MA, Harrison KM, Howlett SJ, Cornes D, Bulsara MK, Hamilton CS, Kron T, Joseph DJ, Denham JW (2011) Dosimetric intercomparison for multicentre clinical trials using a patient-based anatomic pelvic phantom, Med Phys, 38(9): 5167-5175
· Harrison KM, Ebert MA, Kron T, Howlett SJ, Cornes D, Hamilton CS, Denham JW (2011) Design, manufacture and evaluation of an anthropomorphic pelvic phantom purpose-built for radiotherapy dosimetric intercomparison, Med Phys, 38(10): 5330-5337
· Lamb DS, Denham JW, Joseph D, Matthews J, Atkinson C, Spry NA, Duchesne G, Ebert M, Steigler A, Delahunt B, and D’Este C. (2011) A comparison of the prognostic value of early PSA based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial. Int J Radiat Oncol Biol Phys, 79(2): 385-391
· Ebert MA, Haworth A, Kearvell R, Hooton B, Hug B, Spry NA, Bydder SA, Joseph DJ (2010) Comparison of DVH data from multiple radiotherapy treatment planning systems, Phys Med Biol, 55:N337-N346
· Ebert MA, Harrison K, Cornes D, Howlett SJ, Joseph DJ, Kron T, Hamilton CS, Denham JW (2009) Comprehensive Australasian multi-centre dosimetric intercomparison: issues, logistics and recommendations, J Med Imag Radiat Oncol, 53; 119-131
· Ebert MA, Howlett SJ, Harrison K, Cornes D, Hamilton CS, Denham JD (2008) Linear-accelerator X-ray output: a multicentre chamber-based intercomparison study in Australia and New Zealand, Aust Phys Eng Sci Med, 31(4): 268-279
· Ebert MA, Haworth A, Kearvell R, Hooton B, Coleman R, Spry N, Bydder S, Joseph D (2008) Detailed review and analysis of complex radiotherapy clinical trial planning data: Evaluation and initial experience with the SWAN software system, Radiotherapy and Oncology, 86: 200-210
· Spry N, Bydder S, Harvey J, Borg M, Ngan S, Millar J, Graham P, Zissiadis Y, Kneebone A, Ebert, M (2008) Accrediting radiation technique in a multicentre trial of chemoradiation for pancreatic cancer Journal of Medical Imaging and Radiation Oncology, 52(6):598-604
· Osborne C, Bydder SA, Ebert MA, Spry NA. (2006) Comparison of non-coplanar and coplanar irradiation techniques to treat cancer of the pancreas. Austral Radiol.; 50(5):463-7
· Osborne C, Spry NA, Bydder S, Ebert MA (2006) Non coplanar radiotherapy has advantages over coplanar radiotherapy for pancreatic cancer: Evaluating competing radiation techniques when there are multiple organs at risk, Austral Radiol 50(6): 455-462.
· Hamilton, C.S. and Ebert, M.A. (2005) Volumetric uncertainty in radiotherapy, Clinical Oncology, 17, 456-464.
· M.A.Ebert, J.Blight, S.Price, A.Haworth, C.Hamilton, D.Cornes, D.J.Joseph (2004) Multi-centre analysis of treatment planning information: technical requirements, possible applications and a proposal. Austr. Radiol. 48, 347-352.